[
    [
        {
            "time": "2019-04-29",
            "original_text": "【西南医药】片仔癀（600436）：核心产品高基数新增速，日化板块略超预期",
            "features": {
                "keywords": [
                    "片仔癀",
                    "核心产品",
                    "高基数",
                    "新增速",
                    "日化板块",
                    "超预期"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【西南医药】片仔癀（600436）：核心产品高基数新增速，日化板块略超预期",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-04-29",
            "original_text": "【华泰医药代雯团队】片仔癀 (600436) 季报点评：高基数下维持快速增长",
            "features": {
                "keywords": [
                    "片仔癀",
                    "季报",
                    "高基数",
                    "快速增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【华泰医药代雯团队】片仔癀 (600436) 季报点评：高基数下维持快速增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-04-29",
            "original_text": "片仔癀：业绩符合预期，同比高基数下增速可观",
            "features": {
                "keywords": [
                    "片仔癀",
                    "业绩",
                    "符合预期",
                    "高基数",
                    "增速可观"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "片仔癀：业绩符合预期，同比高基数下增速可观",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-29",
            "original_text": "【东吴医药】医药周观点20190429:基金医药持仓比例11.3%，较2018年略有提升，建议积极关注有业绩保障的公司",
            "features": {
                "keywords": [
                    "基金医药持仓",
                    "比例提升",
                    "业绩保障",
                    "建议关注"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【东吴医药】医药周观点20190429:基金医药持仓比例11.3%，较2018年略有提升，建议积极关注有业绩保障的公司",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-04-29",
            "original_text": "片仔癀主业成本上涨压力凸显 多元业务发展步伐缓慢",
            "features": {
                "keywords": [
                    "片仔癀",
                    "主业成本",
                    "上涨压力",
                    "多元业务",
                    "发展缓慢"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "片仔癀主业成本上涨压力凸显 多元业务发展步伐缓慢",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-29",
            "original_text": "【中银医药】片仔癀2019Q1点评：业绩增速略低于预期，透视“低于预期”背后的原因",
            "features": {
                "keywords": [
                    "片仔癀",
                    "2019Q1",
                    "业绩增速",
                    "低于预期",
                    "原因分析"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【中银医药】片仔癀2019Q1点评：业绩增速略低于预期，透视“低于预期”背后的原因",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]